RIÑÓN Y ENFERMEDAD CARDIOVASCULAR - Seden

BIBLIOGRAFÍA
172. Matixx HJ, Hsu C-Y, Shaykevich S, Curhan G: Use of the
albumin/creatinine ratio to detect microalbuminuria: implications
of sex and race. J Am Soc Nephrol 13: 1034-1039,
2002.
173. Tamura S, Shimizu T, Kawakatsu H, Tateishi S: Correlation
between 24-hour urinary protein excretion and protein/creatinine
ratio in the first voided morning urine sample.
Nippon Jinzo Gakkai Shi 46: 26-34, 2004.
174. Wachtell K, Visen H, Olsen MH, Borch-Johnsen K, Lindholm
LH, Mogensen CE, y cols. Albuminuria and cardiovascular
risk in hypertensive patients with left ventricular hypertrophy:
the LIFE study. Ann Intern Med 139: 901-906, 2003.
175. Meinhardt U, Ammann RA, Fluck C, Diem P, Mullis PE:
Microalbuminuria in diabetes mellitus: efficacy of a new
screening method in comparison with timed overnight urine
collection. J Diabetes Complications 17: 254-257, 2003.
176. Gerber LM, Johnston K, Alderman MH: Assessment of a new
dipstick test in screening for microalbuminuria in patients
with hypertension. Am J Hypertens 11: 1321-1327, 1998.
177. Agarwal R, Panesar A, Lewis RR: Dipstick proteinuria: can it
guide hypertension management? Am J Kidney Dis 39:
1190-1195, 2002.
178. Baskar V, Kamalakannan D, Holland MR, Catchpole CR,
Singh BM. Uncertain clinical utility of contemporary strategies
for microalbuminuria testing. Diabetes Obes Metab 5:
262-266, 2003.
179. Jones CA, Francis ME, Eberhardt MS, Chavers B, Coresh J,
Kusek JW, y cols. Microalbuminuria in the US population:
third National Health Nutrition Examination Survey. Am J
Kidney Dis 39: 445-459, 2002.
180. Brown WW, Peters RM, Ohmit SE, Keane WF, Collins A,
Chen SC, y cols. Early detection of kidney disease in community
settings: the Kidney Early Evaluation Program (KEEP).
Am J Kidney Dis 42: 22-35, 2003.
181. Jensen JS, Clausen P, Borch-Johnsen K, Jensen G: Detecting
microalbuminuria by urinary albumin/creatinine concentration
ratio. Nephrol Dial Transplant 12 (suppl 2): 6-9, 1997.
182. Gai M, Motta D, Cantaluppi V, Fop F, Jeantet A, Segoloni GP,
y cols. Proteinuria dipstick test: is it time to change? Kidney
Int 63: 2326-2327, 2003.
183. Chadban SJ, Briganti EM, Kerr PG, Dunstan DW, Welborn
TA, Zimmet PZ, y cols. Prevalence of kidney damage in australian
adults: the AusDiab Kidney Study. J Am Soc Nephrol
14: S131-S138, 2003.
184. Iseki K, Ikemiya Y, Iseki C, Takishita S: Proteinuria and the
risk of developing end-stage renal disease. Kidney Int 63:
1468-1474, 2003.
185. Kannel WB, Stampfer MJ, Castelli WP, Verter J: The prognostic
significance of proteinuria: the Framigham study. Am
Heart J 108: 1347-1352, 1984.
186. Romundstad S, Holmen J, Kvenild K, Aakervik O, Hallan H:
Clinical relevance of microalbuminuria screening in selfreported
diabetic/non-hypertensive persons identified in a
large health screening-the Nord-Trondelag Health Study
(HUNT), Norway. Clin Nephrol 59: 241-251, 2003.
187. Topham PS, Jethwa A, Watkins M, Rees Y, Feehally J: The
value of urine screening in a young adult population. Fam
Pract 21: 18-21, 2004.
188. Iseki K, Iseki C, Ikemiya Y, Fukiyama K: Risk of developing
end-stage renal disease in a cohort of mass screening.
Kidney Int 49: 800-805, 1996.
189. Allwall N, Lohi A. A population study on renal and urinary
tract diseases. Acta Med Scand 194: 525-528, 1973.
190. Ruiz JC, López G. Técnicas de imagen en nefrología. En:
Nefrología clínica. Hernando L, ed. Editorial Panamericana,
2º edición. Madrid 2003, 135-144.
191. Marín R, Gorostidi M, Pobes A: Hipertensión arterial y enfermedad
vascular renal: nefroangioesclerosis. Nefrología 22
(suppl 1): 36-45, 2002.
192. Marín R, Gorostidi M: Nefroesclerosis. En: Hernando L,
Aljama P, Arias M, Caramelo C, Ejido J, Lamas S, eds.
Nefrología clínica. Madrid: Editorial Médica Panamericana:
221-232, 2003.
193. Ruilope LM: The kidney and cardiovascular risk. Nephrol
Dial Transplant 12: 243-245, 1997.
194. Ruilope LM: The kidney as part of the cardiovascular system.
J Cardiovasc Pharmacol 33 (suppl 1): S7-S10, 1999.
195. Ruilope LM, van Veldhuisen DJ, Ritz E, Luscher TF: Renal
function: the Cinderella of cardiovascular risk profile. J Am
Coll Cardiol 38: 1782-1787, 2001.
196. Ruilope LM: The kidney as a sensor of cardiovascular risk in
essential hypertension. J Am Soc Nephrol 13: S165-S168,
2002.
197. Kasiske BL: The kidney in cardiovascular disease. Ann Intern
Med 134: 707-709, 2001.
198. Campo C, Segura J, Ruilope LM: Riesgo cardiovascular asociado
a la insuficiencia renal. Hipertensión 18: 285-290,
2001.
199. Pérez I, Luño J: La insuficiencia renal es un importante factor
de riesgo cardiovascular. Nefrología 22: 306-309, 2002.
200. Ritz E: Minor renal dysfunction: an emerging independent
cardiovascular risk factor. Heart 89: 963-964, 2003.
201. Ritz E, McClellan WM: Overview: increased cardiovascular
risk in patients with minor renal dysfunction: an emerging
issue with far-reaching consequences. J Am Soc Nephrol 15:
513-16, 2004.
202. Best PJ, Holmes DR: Chronic kidney disease as a cardiovascular
risk factor. Am Heart J 145: 383-386, 2003.
203. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH:
Longitudinal follow-up and outcomes among a population
with chronic kidney disease in a large managed care organization.
Arch Intern Med 164: 659-663, 2004.
204. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green
LA, Izzo JL Jr, y cols. The seventh report of the Joint National
Committee on Prevention, Detection, Evaluation and
Treatment of High Blood Pressure: the JNC 7 report. JAMA
289: 2560-2572, 2003.
205. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green
LA, Izzo JL Jr, y cols. Seventh report of the Joint National
Committee on Prevention, Detection, Evaluation and
Treatment of High Blood Pressure. JNC 7 – Complete version.
Hypertension 42: 1206-1252, 2003.
206. Guidelines Committee: 2003 European Society of
Hypertension – European Society of Cardiology guidelines
for the management of arterial hypertension. J Hypertens 21:
1011-1053, 2003.
207. Culleton BF, Larson MG, Evans JC, Wilson PWF, Barrett BJ,
Parfrey PS, y cols. Prevalence and correlates of serum creatinine
levels. The Framingham Heart Study. Arch Intern Med
159: 1785-1790, 1999.
192